01959nam a2200265   4500001000800000005001700008007000300025008004100028040000800069041000800077100002400085245005800109300002300167520120000190650003601390650001901426650001801445650001601463650002801479700002201507700002301529700002001552700001801572773010301590ESSALUD20260817144932.0ta      t        pe ||||| |||| 00| 0 spa d  aBMG  aeng  aCho, Hae LineAutor  aConsumed with Inflammation.bClinical Problem-Solving  apáginas: 593-598  aA 60-year-old woman with stage II triple-negative breast cancer presented to the emergency department with a weeklong history of fevers, rigors, malaise, nonproductive cough, and nausea. She reported intermittent lightheadedness, headaches, and neck pain when febrile but no sore throat, rhinorrhea, shortness of breath, vomiting, abdominal pain, or dysuria. She noted no recent travel or sick contacts. Two months before presentation, she completed neoadjuvant carboplatin, paclitaxel, and doxorubicin and then, 1 month before presentation, underwent lumpectomy of the left breast and sentinel-lymph-node biopsy. She had also been treated as part of a clinical trial with multiple cycles of pembrolizumab (first dose, 6 months before presentation; last dose, 6 days before presentation). Although she had had transient neutropenia from chemotherapy, her white-cell counts had normalized after her last cycle. Postoperatively, mild tenderness and swelling around her left axilla had developed without systemic signs of infection; computed tomographic (CT) imaging was consistent with an uncomplicated seroma. In the days leading up to this presentation, her tenderness in this area had resolved.  aMEDICINA CLÍNICA HOSPITALARIA  aCANCER DE MAMA  aHEMATOLOGÍA  aONCOLOGÍA  aENFERMEDAD INFLAMATORIA  aBerliner, Nancy    aBabcock, Stephen    aSun, Yee-Ping    aLevy , Bruce 0 022717dMassachusetts NEJM GroupoNEJM009tThe New England Journal of Medicine wESSALUDx0028-4793